Effect of Albiglutide, When Added to Standard Blood Glucose Lowering Therapies, on Major Cardiovascular Events in Subjects With Type 2 Diabetes Mellitus
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 9463 participants.
Also called NCT02465515
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 9,463 participants
- Registry
-
NCT02465515 -
2014-001824-32
-
- Other papers using this trial's data
- Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial
- Effect of albiglutide on cardiovascular outcomes in older adults: A post hoc analysis of a randomized controlled trial
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States, Argentina, Belgium, Bulgaria, Canada, Czechia, Denmark, France, Germany, Greece, Hong Kong SAR China, Hungary, Italy, Mexico, Netherlands, Norway, Peru, Philippines, Poland, Russia, South Africa, South Korea, Spain, Sweden, Taiwan, Thailand, Ukraine, United Kingdom
- Registry status
- Completed
Technical summary
Registry record NCT02465515. Randomized; quadruple masking; primary purpose treatment. Start 2015-07-01 (actual); primary completion 2018-02-20 (actual). Results posted on 2019-03-06.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Effect of Albiglutide, When Added to Standard Blood Glucose Lowering Therapies, on Major Cardiovascular Events in Subjects With Type 2 Diabetes Mellitus
- Condition
- Diabetes Mellitus
- Intervention (Biological)
- Albiglutide 30 mg
- Intervention (Biological)
- Albiglutide 50 mg
- Intervention (Biological)
- Albiglutide matching placebo
- Lead sponsor
- GlaxoSmithKline
- Collaborator
- Duke Clinical Research Institute
Record details
- Record id
cardio:ct-nct02465515- Content hash
f3ecd7fd5fb3cec5ba5873801952129968966b6b55e93fc4ba528dcf0c153a35